Edwards Lifesciences EW
NYSE EW
$86.65 +0.47 (+0.55%)
As of: Sep 10, 2026 · 11:51 AM EDT

Edwards Lifesciences (EW) Capital Expenditures Growth (5y) (2014 - 2026)

Analysis

Edwards Lifesciences (EW) Capital Expenditures Growth (5y) (2014 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 181.40 Bn 175.80 Bn 7.27 Bn
2 Intuitive Surgical 127.77 Bn 122.55 Bn 1.96 Bn
3 Medtronic 117.21 Bn 108.39 Bn 6.34 Bn
4 Stryker 105.12 Bn 101.64 Bn 4.50 Bn
5 Boston Scientific 64.52 Bn 63.98 Bn 3.85 Bn
6 Edwards Lifesciences 49.95 Bn 45.69 Bn 1.35 Bn
7 Alcon 33.09 Bn 31.63 Bn 1.68 Bn
8 Dexcom 32.17 Bn 30.23 Bn 830.00 Mn
9 Steris 20.75 Bn 20.27 Bn 684.20 Mn
10 Zimmer Biomet Holdings 17.78 Bn 17.37 Bn 1.54 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.70%
Mar 31, 2026 -9.35%
Dec 31, 2025 -2.96%
Sep 30, 2025 -11.06%
Jun 30, 2025 -14.56%
Mar 31, 2025 -7.39%
Dec 31, 2024 -6.98%
Sep 30, 2024 -7.37%
Jun 30, 2024 5.74%
Mar 31, 2024 9.12%
Dec 31, 2023 8.92%
Sep 30, 2023 -8.26%
Jun 30, 2023 -1.93%
Mar 31, 2023 7.32%
Dec 31, 2022 5.83%
Sep 30, 2022 7.21%
Jun 30, 2022 -5.77%
Mar 31, 2022 35.53%
Dec 31, 2021 7.28%
Sep 30, 2021 4.76%